FDA Inspection 1101474 — Medrange Corporation
The FDA completed an inspection of Medrange Corporation on August 12, 2019 in Brea, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 12, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Brea, CA (United States)